BR9812861A - Formulações parenterais compreendendo carbamazepina ou seus derivados - Google Patents

Formulações parenterais compreendendo carbamazepina ou seus derivados

Info

Publication number
BR9812861A
BR9812861A BR9812861-2A BR9812861A BR9812861A BR 9812861 A BR9812861 A BR 9812861A BR 9812861 A BR9812861 A BR 9812861A BR 9812861 A BR9812861 A BR 9812861A
Authority
BR
Brazil
Prior art keywords
carbamazepine
derivatives
parenteral formulations
parenteral formulation
seizures
Prior art date
Application number
BR9812861-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Peter Van Hoogevest
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR9812861A publication Critical patent/BR9812861A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
BR9812861-2A 1997-10-09 1998-10-07 Formulações parenterais compreendendo carbamazepina ou seus derivados BR9812861A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9721497.7A GB9721497D0 (en) 1997-10-09 1997-10-09 Organic compounds
PCT/EP1998/006382 WO1999018966A1 (en) 1997-10-09 1998-10-07 Parenteral formulations comprising carbamazepine or its derivatives

Publications (1)

Publication Number Publication Date
BR9812861A true BR9812861A (pt) 2000-08-08

Family

ID=10820342

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9812861-2A BR9812861A (pt) 1997-10-09 1998-10-07 Formulações parenterais compreendendo carbamazepina ou seus derivados

Country Status (31)

Country Link
US (2) US6316417B1 (enExample)
EP (1) EP1033988B1 (enExample)
JP (2) JP2001519395A (enExample)
KR (1) KR100760326B1 (enExample)
CN (1) CN1210032C (enExample)
AR (1) AR015465A1 (enExample)
AT (1) ATE257383T1 (enExample)
AU (1) AU748034B2 (enExample)
BR (1) BR9812861A (enExample)
CA (1) CA2304661C (enExample)
CO (2) CO4950520A1 (enExample)
CZ (1) CZ298900B6 (enExample)
DE (1) DE69821024T2 (enExample)
DK (1) DK1033988T3 (enExample)
ES (1) ES2214738T3 (enExample)
GB (1) GB9721497D0 (enExample)
HU (1) HU226106B1 (enExample)
ID (1) ID24134A (enExample)
IL (1) IL135123A0 (enExample)
MY (1) MY122129A (enExample)
NO (1) NO327263B1 (enExample)
NZ (1) NZ503526A (enExample)
PE (1) PE121998A1 (enExample)
PL (1) PL192287B1 (enExample)
PT (1) PT1033988E (enExample)
RU (1) RU2242231C2 (enExample)
SK (1) SK286253B6 (enExample)
TR (1) TR200000870T2 (enExample)
TW (1) TW584563B (enExample)
WO (1) WO1999018966A1 (enExample)
ZA (1) ZA989183B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
WO2007041524A2 (en) * 2005-09-30 2007-04-12 Ovation Pharmaceuticals, Inc. Novel parenteral carbamazepine formulation
US20100204178A1 (en) 2006-10-02 2010-08-12 James Cloyd Novel parenteral carbamazepine formulation
KR101478164B1 (ko) * 2006-02-09 2014-12-31 산텐 세이야꾸 가부시키가이샤 안정한 제제와 그 제조 및 사용 방법
US8372431B2 (en) 2007-10-26 2013-02-12 Bial-Portela & C.A., S.A. Pharmaceutical composition comprising licarbazepine acetate
CN101711739B (zh) * 2008-10-08 2012-07-04 中国人民解放军军事医学科学院毒物药物研究所 卡马西平的口服药物组合物
CN105726466A (zh) * 2014-12-10 2016-07-06 辽宁药联制药有限公司 一种奥卡西平注射剂及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202311A (en) * 1988-08-19 1993-04-13 Children's Medical Center Corporation Stabilized fgf composition
EP0435826A1 (de) * 1989-12-27 1991-07-03 Ciba-Geigy Ag Intravenöse Lösungen für Status Epilepticus
ES2081965T3 (es) * 1989-12-27 1996-03-16 Ciba Geigy Ag Dispositivo para homogenizar la distribuccion no homogenea de la luz de un haz de rayos laser.
US5284662A (en) * 1990-10-01 1994-02-08 Ciba-Geigy Corp. Oral osmotic system for slightly soluble active agents
RU2020972C1 (ru) * 1991-02-07 1994-10-15 Мегдятов Рашид Салехович Способ лечения невралгии тройничного нерва
US5231089A (en) * 1991-12-02 1993-07-27 University Of Florida Method of improving oral bioavailability of carbamazepine
FR2702148B1 (fr) 1993-03-05 1995-04-07 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement du neuro-sida.
US5472714A (en) * 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
US5466683A (en) * 1994-08-25 1995-11-14 Teva Pharmaceutical Industries Ltd. Water-soluble analogs of carbamazepine

Also Published As

Publication number Publication date
US6316417B1 (en) 2001-11-13
RU2242231C2 (ru) 2004-12-20
PT1033988E (pt) 2004-05-31
HUP0004362A3 (en) 2006-06-28
KR20010072533A (ko) 2001-07-31
ES2214738T3 (es) 2004-09-16
CA2304661C (en) 2007-12-11
SK5052000A3 (en) 2000-12-11
PL339446A1 (en) 2000-12-18
PE121998A1 (es) 1999-12-08
ID24134A (id) 2000-07-06
NO20001730L (no) 2000-04-04
SK286253B6 (sk) 2008-06-06
EP1033988A1 (en) 2000-09-13
KR100760326B1 (ko) 2007-09-20
CZ298900B6 (cs) 2008-03-05
TW584563B (en) 2004-04-21
DE69821024T2 (de) 2004-10-28
CO4950520A1 (es) 2000-09-01
HK1031824A1 (en) 2001-06-29
NO20001730D0 (no) 2000-04-04
AR015465A1 (es) 2001-05-02
HU226106B1 (en) 2008-04-28
ZA989183B (en) 1999-04-09
CN1210032C (zh) 2005-07-13
GB9721497D0 (en) 1997-12-10
JP2005281314A (ja) 2005-10-13
CO5090854A1 (es) 2001-10-30
NZ503526A (en) 2003-01-31
IL135123A0 (en) 2001-05-20
EP1033988B1 (en) 2004-01-07
HUP0004362A2 (hu) 2001-08-28
US20020055503A1 (en) 2002-05-09
DK1033988T3 (da) 2004-04-13
DE69821024D1 (de) 2004-02-12
CA2304661A1 (en) 1999-04-22
ATE257383T1 (de) 2004-01-15
NO327263B1 (no) 2009-05-25
PL192287B1 (pl) 2006-09-29
MY122129A (en) 2006-03-31
US6458770B1 (en) 2002-10-01
TR200000870T2 (tr) 2000-10-23
CN1274286A (zh) 2000-11-22
AU9629898A (en) 1999-05-03
AU748034B2 (en) 2002-05-30
CZ20001279A3 (cs) 2000-07-12
WO1999018966A1 (en) 1999-04-22
JP2001519395A (ja) 2001-10-23

Similar Documents

Publication Publication Date Title
AU1973997A (en) Pentafluorobenzenesulfonamides and analogs
DE69333062D1 (de) 4-mercaptoacetylamino-[2]benzazepinon(3)- derivate, und verwendung als enkephalinase-inhibitoren
EA200100519A1 (ru) Композиции на основе тонкоизмельченного эплеренона
DE69516128D1 (de) Mercaptoacetylamid-1,3,4,5-tetrahydrobenzo(c)azepin-3-ein disulfidderivate als enkephalinase und ace inhibitoren
AUPP000797A0 (en) Fixation of cruciate ligament grafts
BR9710994A (pt) Derivados anticonvulsivos úteis no tratamento de obesidade.
IL129592A0 (en) 5-HT1f agonists
AR038431A2 (es) Derivados 2-desoxo-15-alquilo de marcfortina
ATE368650T1 (de) Kondensierte azepinderivate und ihre verwendung als als antidiuretisches mittel
EP1074549A3 (en) Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors
NO944781D0 (no) 2,5-diokso-2,5-dihydro-1H-benz(b)azepiner som NMDA-reseptor-antagonister
CA2094702A1 (en) Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents
ATE235472T1 (de) N-(2-oxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepi - 3-yl)-3-amide
CA2094703A1 (en) Substituted piperazines as central nervous system agents
DE69814735D1 (de) Carbazolcarboxamide als 5-HT1F Agonisten
BR9907655A (pt) Derivados de ácido di-hidróxi-hexanóico
TR200000870T2 (tr) Karbamazepin veya türevlerinden oluşan parenteral formülasyonlar.
PT763047E (pt) Novo processo para a preparacao de nucleosidos
NO20002408D0 (no) 5-HT1F antagonister
FI905957A0 (fi) Foerfarande foer framstaellning av substituerade cyklohexener, som verkar pao det centrala nervsystemet.
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
NO923266L (no) Heksahydrobenzo(f)quinolinoner
YU47379B (sh) POBOLJŠANI POSTUPAK ZA DOBIJANJE 5-KARBAMOIL-5H-DIBENZ(b;f) AZEPINA
ATE141604T1 (de) Antikonvulsive pirazine
PH24501A (en) Substituted 3-phenyl-7h-thiazolo(3,2-b)(1,2,4)triazin-7-ones

Legal Events

Date Code Title Description
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO COM BASE NOS ARTIGOS 8O E 13 DA LEI 9279/96 (LPI)

B12B Appeal against refusal [chapter 12.2 patent gazette]